Personalized shield: daily pill aims to block deadly infections for new kidney recipients
NCT ID NCT07407673
Summary
This study aims to prevent dangerous bloodstream infections in people who have recently received a kidney transplant. It will test if a daily antibiotic pill, given for five months to patients identified as high-risk, is better than a placebo at stopping these infections. The goal is to see if this personalized prevention strategy can keep transplant patients healthier and out of the hospital.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus University Hospital
Aarhus, Denmark
Contact
-
Odense University Hospital
Odense, Denmark
Contact
-
Rigshospitalet
Copenhagen, 2100, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.